Contact Us
Drug Search Results
More Filters [+]

Nefopam

Alternative Names: nefopam
Latest Update: 2024-12-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: NMDA Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Bangladesh | Belgium | Chile | Colombia | Cyprus | Egypt | Estonia | France | India | Ireland | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | New Zealand | Pakistan | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Taiwan | Tunisia | Ukraine | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Unither, France
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nefopam

Countries in Clinic: Belgium, France, Hungary, Russia, United Kingdom

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Acute Pain|Pain Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
METAPAIN

P3

Completed

Pain Unspecified

2022-10-20

UP-CLI-2019-002

P3

Completed

Acute Pain

2022-10-12

Recent News Events

Date

Type

Title

05/02/2024

PubMed

 Evaluating the Efficacy of Methocarbamol and Nefopam in Orthopedic Surgical Pain.

03/28/2024

PubMed

 Prevention of postoperative nausea and vomiting after orthognathic surgery: a scoping review.

02/23/2024

PubMed

 Efficacy of Oral Nefopam on Multimodal Analgesia in Total Knee Arthroplasty: A Prospective, Double-Blind, Placebo-Controlled, Randomized Trial.

03/07/2022

News Article

 Global Nefopam (CAS 13669-70-0) Market Research Report 2022 - ResearchAndMarkets.com

04/10/2019

News Article

 Scar - Pipeline Review, H1 2019 - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions